What GLP-1 Treatment Costs
What semaglutide and tirzepatide actually cost through clinics and telehealth, and how to avoid hidden fees.
How much does GLP-1 weight-loss treatment cost?
GLP-1 weight-loss treatment is priced in two very different worlds: FDA-approved brand-name medication sold by the manufacturer, and compounded semaglutide or tirzepatide mixed by a licensed pharmacy. The gap between them is large, and the real cost of a program is more than the price on the medication itself. This guide breaks down what each layer costs and how to compare clinics on price without getting surprised later.
Brand vs. compounded: the price gap
Semaglutide is sold as Wegovy (weight loss) and Ozempic (type 2 diabetes). Tirzepatide is sold as Zepbound (weight loss) and Mounjaro (type 2 diabetes). At the retail/list cash price, brand medication runs roughly $1,000–$1,600 per month. The manufacturers also run direct self-pay programs (NovoCare, LillyDirect) that price brand product materially lower for those who qualify. Verify the current amount directly, as it changes often. Compounded versions of the same active ingredients, from a licensed 503A or 503B pharmacy, run roughly $200–$500 per month.
Compounded GLP-1s are not FDA-approved. As brand-name shortages resolved, the FDA tightened access to compounded semaglutide and tirzepatide, so availability varies by state and by month. A legitimate clinic will name its compounding pharmacy and disclose 503A vs. 503B status. If it will not name the pharmacy, treat that as a red flag.
| Medication | Brand (retail, cash) | Compounded (503A/503B) |
|---|---|---|
| Semaglutide (Wegovy / Ozempic) | ~$1,000–$1,600 / mo | $200–$400 / mo |
| Tirzepatide (Zepbound / Mounjaro) | ~$1,000–$1,600 / mo | $250–$500 / mo |
Compounded tirzepatide typically runs $50–$100 more per month than compounded semaglutide. Brand retail figures are before any manufacturer savings card, self-pay program, or insurance. Confirm current manufacturer self-pay and savings-card pricing directly at NovoCare (Novo Nordisk) and LillyDirect (Eli Lilly) before relying on a number.
What actually drives the price
The medication is only part of the bill. When you compare two clinics, four cost drivers explain most of the difference:
- Brand vs. compounded. The single biggest lever. Compounded is far cheaper but not FDA-approved; brand is FDA-approved but expensive without coverage.
- Consult and follow-ups. A legitimate program requires a real clinical evaluation before prescribing and ongoing follow-up. Some telehealth plans bundle these into the monthly price; in-person clinics often bill them separately.
- Labs. Baseline and follow-up labs are part of responsible care. Ask whether labs are included, billed separately, or expected to run through your own insurance.
- Membership and dose. Some clinics charge a monthly membership on top of medication, and higher maintenance doses can cost more. A low starter price can climb as your dose escalates.
Is cash-pay or insurance cheaper for GLP-1s?
How to compare clinics on price transparency
Price transparency is one of the seven dimensions we grade clinics on. A clinic that publishes itemized pricing (consult, medication, labs, and any membership) is easier to trust than one that hides pricing behind “book a call.” Before you commit, get clear answers to:
- Is the price all-inclusive, or are labs and consults billed separately?
- Is this brand or compounded medication, and which pharmacy fills it?
- Does the price change as my dose increases?
- Is there a monthly membership fee on top of the medication?
- What am I charged if I pause or cancel?
A clinic that answers these plainly, in writing, is showing you the kind of transparency our grades reward. One that dodges them is telling you something too. See how we score pricing transparency in our grading methodology, or compare graded clinics side by side.
This guide is informational and not medical or financial advice. Prices change frequently and vary by clinic, state, and dose. Confirm current pricing directly with the clinic and discuss treatment decisions with a licensed provider.